Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Evan Siegelman

Diagnostic Radiology Philadelphia, PA Medical Doctor

NPI 1376571422 CMS profile 943446

3400 Spruce St, Ground Floor Dulles, Philadelphia, PA 19104

Open in the dashboard

General payments

$703,913

180 records reported · program years 2019–2025

Research payments

$423,829

Paid to them · 19 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Evan Siegelman of Philadelphia, PA is reported in the CMS Open Payments database as having received $703,913 across 180 general payments and $423,829 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Diagnostic Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

12 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $77 3
2025 Research $19,940 1
2024 Research $67,580 2
2023 General $135 2
2023 Research $65,248 2
2022 Research $129,013 2
2021 General $386,888 60
2021 Research $73,263 8
2020 General $249,186 68
2020 Research $62,110 2
2019 General $67,628 47
2019 Research $6,675 2

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Evan Siegelman
  • Diagnostic Radiology median
  • Middle half of Diagnostic Radiology
  • National median

In program year 2025, general payments to Evan Siegelman were reported at $77. Among 8,325 Diagnostic Radiology profiles paid that year, the median was $112 and the middle half received between $32 and $349.

Show as a table
Year Evan Siegelman Diagnostic Radiology median Middle half National median
2019 $67,628 $108 $29–$318 $163
2020 $249,186 $65 $21–$252 $114
2021 $386,888 $92 $24–$292 $132
2022 $0 $104 $29–$294 $149
2023 $135 $110 $29–$337 $160
2024 $0 $113 $30–$356 $164
2025 $77 $112 $32–$349 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Merck Sharp & Dohme Corporation $703,701 175 payments
  2. Medtronic, Inc. $191 4 payments
  3. Philips Electronics North America Corporation $21 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $703,701 175 payments
  2. Food and Beverage $212 5 payments
Products named General payments · program years 2019–2025
  1. LENVIMA $460,025 63 payments
  2. KEYTRUDA $232,096 111 payments
  3. Abre $191 4 payments
  4. Spectral CT 7500 $21 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. E.R. Squibb & Sons, L.L.C. $386,234 11 payments
  2. EMD Serono, Inc. $30,920 6 payments
  3. Eli Lilly and Company $5,450 1 payment
  4. Celgene Corporation $1,225 1 payment

Billing to Medicare

Part B · data year 2024 · 34 billing codes

Paid by Medicare

$134,503

Medicare's payments for the services billed

Medicare patients

1,440

Average age 72

Services billed

2,431

642 women, 798 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 73%
Cancer 41%
Arthritis 40%
Diabetes 31%
Ischemic heart disease 31%
Chronic kidney disease 30%
Depression 21%
Atrial fibrillation 20%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

199 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Diagnostic Radiology in Pennsylvania

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record